India’s Pharmaceutical Traceability Hit Another Roadblock

The system, proposed in 2011 and aimed at combating counterfeit drugs and improving transparency in drug exports and pharmaceutical supply chain, has been meeting repeated challenges stemming from difficulties within the industry and representation from the industry leaders. Technical obstacles and concerns regarding system readiness have contributed to this hurdle.